SCHEMBL23924451

SCHEMBL23924451

C[C@H]1C[C@@H](Oc2cnc(C#N)cn2)CCN1C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 3/20 0.53
CHEK1 O14757 10/20 0.39
RPS6KA3 P51812 3/20 0.37
SRPK1 Q96SB4 2/20 0.37
JAK3 P52333 1/20 0.36
TRPC3 Q13507 1/20 0.36
TRPC6 Q9Y210 1/20 0.36
CHEK2 O96017 2/20 0.35
BRD4 O60885 2/20 0.35
DPP4 P27487 1/20 0.34
DPP8 Q6V1X1 1/20 0.34
DPP9 Q86TI2 1/20 0.34
CHRM4 P08173 1/20 0.34
FLT4 P35916 2/20 0.33
KDR P35968 2/20 0.33
GSK3B P49841 2/20 0.33
STK3 Q13188 2/20 0.33
PLK4 O00444 1/20 0.33
PDPK1 O15530 1/20 0.33
MAP4K4 O95819 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21665749 0.86 GPR119 (0.67) GPR119MAP4K4
SCHEMBL30938143 0.86 GPR119 (0.67) GPR119MAP4K4
SCHEMBL14634468 0.77 GPR119 (0.73) GPR119JAK3
SCHEMBL14634467 0.77 GPR119 (0.73) GPR119JAK3
SCHEMBL21807918 0.73 HCRTR1 (0.34) GPR119
SCHEMBL21645375 0.72 GPR119 (0.44) GPR119CHEK1TRPC3TRPC6CHEK2
SCHEMBL30991254 0.72 GPR119 (0.44) GPR119CHEK1TRPC3TRPC6CHEK2
SCHEMBL22323337 0.72 GPR119 (0.33) GPR119
Hydrochloric Acid SCHEMBL21645371 0.71 GPR119 (0.43) GPR119CHEK1TRPC3TRPC6CHEK2
Hydrochloric Acid SCHEMBL30991239 0.71 GPR119 (0.43) GPR119CHEK1TRPC3TRPC6CHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11999726-B2 5-methyl-4-fluoro-thiazol-2-yl compounds ELI LILLY AND COMPANY 2024-06-04 US disclosed
EP-3829716-B1 5-METHYL-4-FLUORO-THIAZOL-2-YL COMPOUNDS LILLY CO ELI (US) 2023-02-01 EP disclosed
US-20210323958-A1 5-METHYL-4-FLUORO-THIAZOL-2-YL COMPOUNDS ELI LILLY AND COMPANY 2021-10-21 US disclosed
CN-112469476-A 5-methyl-4-fluoro-thiazol-2-yl compounds 伊莱利利公司 2021-03-09 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210323958-A1 5-METHYL-4-FLUORO-THIAZOL-2-YL COMPOUNDS MAPT, PSEN2, PSEN1 GPR119 316/4885CHEK1 4760/4885RPS6KA3 2991/4885
US-11999726-B2 5-methyl-4-fluoro-thiazol-2-yl compounds MAPT, PSEN2, PSEN1 GPR119 316/4885CHEK1 4760/4885RPS6KA3 2991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.